MyPath for Health specifically connects patients, caregivers, providers, and life sciences organizations, while MyPath for Connected Care provides virtual care services.
Together, the platforms bring together patients and care teams across the entire patient journey, including clinical trials and treatment.
“When used for clinical trials, MyPath gives patients personalized support and information and connects them directly to their care teams,” Christopher Zant, principal, Deloitte Consulting, and chief digital officer, ConvergeHealth by Deloitte, told us.
MyPath for Health delivers care coordination and provides medication and appointment reminders via a 24/7 support network, while enabling remote health and risk monitoring, among other capabilities.
“It can become a digital partner in care,” Zant added, “providing a support network to reduce the patient burden of participating in clinical trials so they can focus on their health.”
The solution collates data from various sources, such as electronic health records (EHRs) and wearables, into a single platform. It also provides integrated analytics capabilities, said Zant, “so patients can share more data with their care teams without increased manual efforts and/or the opportunity for mistakes.”
